Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer

Journal of Biological Chemistry

Volumn 290, Issue 12, 2015, Pages 7345-7359

  Staquicini, Fernanda I ^a,b   Qian, Ming D ^c   Salameh, Ahmad ^c   Dobroff, Andrey S ^a,b   Edwards, Julianna K ^c   Cimino, Daniel F ^a,b   Moeller, Benjamin J ^c,g   Kelly, Patrick ^c,h   Nunez, Maria I ^c   Tang, Ximing ^c   Liu, Diane D ^c   Lee, J Jack ^c   Hong, Waun Ki ^c   Ferrara, Fortunato ^a,b   Bradbury, Andrew R M ^d   Lobb, Roy R ^e   Edelman, Martin J ^e   Sidman, Richard L ^f   Wistuba, Ignacio I ^c   Arap, Wadih ^a,b   Pasqualini, Renata ^a,b   more..

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

^e Arrowhead Research Corporation   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g Levine Cancer Center Institute   (United States)

^h UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIBODIES; BIOLOGICAL ORGANS; CELLS; ENZYMES; MOBILE SECURITY; MONOCLONAL ANTIBODIES; RADIOTHERAPY; RESPIRATORY SYSTEM;

ATAXIA-TELANGIECTASIA MUTATED; CELLULAR RESPONSE; DNA DAMAGES; LUNG CANCER; LUNG CANCER CELLS; MOLECULAR MECHANISM; MOLECULAR TARGETS; RECEPTOR TYROSINE KINASE;

DISEASES;

ATR PROTEIN; DNA; EPHRIN RECEPTOR A5; MONOCLONAL ANTIBODY; EPHA5 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CANCER CELL LINE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RADIOSENSITIVITY; REGULATORY MECHANISM; S PHASE CELL CYCLE CHECKPOINT; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; ENZYMOLOGY; IMMUNOLOGY; LUNG NEOPLASMS; MOLECULARLY TARGETED THERAPY; NUDE MOUSE; NUDE RAT; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RAT; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL CYCLE; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR TARGETED THERAPY; RADIATION TOLERANCE; RATS; RATS, NUDE; RECEPTOR, EPHA5;

EID: 84925433469     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.630525     Document Type: Article

References (40)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., and Parkin, D. M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917
2. Jemal, A., Center, M. M., DeSantis, C., and Ward, E. M. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893-1907
3. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300
4. Herbst, R. S., Heymach, J. V., and Lippman, S. M. (2008) Lung cancer. N. Engl. J. Med. 359, 1367-1380
5. Rengan, R., Maity, A. M., Stevenson, J. P., and Hahn, S. M. (2011) New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease. Clin. Cancer Res. 17, 4192-4199
6. Jackson, S. P., and Bartek, J. (2009) The DNA-damage response in human biology and disease. Nature 461, 1071-1078
7. Cimprich, K. A., and Cortez, D. (2008) ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9, 616-627
8. Bartek, J., and Lukas, J. (2007) DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19, 238-245
9. Shiloh, Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3, 155-168
10. Xu, B., O'Donnell, A. H., Kim, S. T., and Kastan, M. B. (2002) Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res. 62, 4588-4591
11. Bao, S., Tibbetts, R. S., Brumbaugh, K. M., Fang, Y., Richardson, D. A., Ali, A., Chen, S. M., Abraham, R. T., and Wang, X. F. (2001) ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature 411, 969-974
12. Pandita, T. K., Lieberman, H. B., Lim, D. S., Dhar, S., Zheng, W., Taya, Y., and Kastan, M. B. (2000) Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 19, 1386-1391
13. 2/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 22, 1049-1059
14. Kolonin, M. G., Bover, L., Sun, J., Zurita, A. J., Do, K. A., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Jaalouk, D. E., Ozawa, M. G., Moya, C. A., Souza, G. R., Staquicini, F. I., Kunyiasu, A., Scudiero, D. A., Holbeck, S. L., Sausville, E. A., Arap, W., and Pasqualini, R. (2006) Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res. 66, 34-40
15. Pasquale, E. B. (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133, 38-52
16. Pasquale, E. B. (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180
17. Taylor, V., Miescher, G. C., Pfarr, S., Honegger, P., Breitschopf, H., Lassmann, H., and Steck, A. J. (1994) Expression and developmental regulation of Ehk-1, a neuronal Elk-like receptor tyrosine kinase in brain. Neuroscience 63, 163-178
18. Zhou, R. (1997) Regulation of topographic projection by the Eph family receptor Bsk (EphA5) and its ligands. Cell Tissue Res. 290, 251-259
19. Murai, K. K., and Pasquale, E. B. (2002) Can Eph receptors stimulate the mind? Neuron 33, 159-162
20. Fu, D. Y., Wang, Z. M., Wang, B. L., Chen, L., Yang, W. T., Shen, Z. Z., Huang, W., and Shao, Z. M. (2010) Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Hum. Pathol. 41, 48-58
21. Giaginis, C., Tsourouflis, G., Zizi-Serbetzoglou, A., Kouraklis, G., Chatzopoulou, E., Dimakopoulou, K., and Theocharis, S. E. (2010) Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma. Pathol. Oncol. Res. 16, 267-276
22. Pejovic, T., Pande, N. T., Mori, M., Mhawech-Fauceglia, P., Harrington, C., Mongoue-Tchokote, S., Dim, D., Andrews, C., Beck, A., Tarumi, Y., Djilas, J., Cappuccini, F., Caballero, O., Huang, J., Levy, S., Tsiamouri, A., Cain, J., Bagby, G. C., Strausberg, R. L., Simpson, A. J., and Odunsi, K. O. (2009) Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl. Oncol. 2, 341-349
23. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R. A., Shapiro, L. H., Arap, W., and Ruoslahti, E. (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60, 722-727
24. Prudkin, L., Behrens, C., Liu, D. D., Zhou, X., Ozburn, N. C., Bekele, B. N., Minna, J. D., Moran, C., Roth, J. A., Ji, L., and Wistuba, I. I. (2008) Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin. Cancer Res. 14, 41-47
25. Hoppin, J., Orcutt, K. D., Hesterman, J. Y., Silva, M. D., Cheng, D., Lackas, C., and Rusckowski, M. (2011) Assessing antibody pharmacokinetics in mice with in vivo imaging. J. Pharmacol. Exp. Ther. 337, 350-358
26. Bandyopadhyay, D., Mandal, M., Adam, L., Mendelsohn, J., and Kumar, R. (1998) Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J. Biol. Chem. 273, 1568-1573
27. Dittmann, K., Mayer, C., Fehrenbacher, B., Schaller, M., Raju, U., Milas, L., Chen, D. J., Kehlbach, R., and Rodemann, H. P. (2005) Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem. 280, 31182-31189
28. Lin, S. Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., and Hung, M. C. (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3, 802-808
29. Yarden, Y. (2001) The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37, (Suppl. 4) S3-S8
30. Citri, A., and Yarden, Y. (2006) EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7, 505-516
31. Lo, H. W., Hsu, S. C., and Hung, M. C. (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 95, 211-218
32. Huang, P. H., Xu, A. M., and White, F. M. (2009) Oncogenic EGFR signaling networks in glioma. Sci. Signal. 2, re6
33. Ferrara, F., Naranjo, L. A., Kumar, S., Gaiotto, T., Mukundan, H., Swanson, B., and Bradbury, A. R. (2012) Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. PLoS One 7, e49535
34. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597
35. Ambrose, M., and Gatti, R. A. (2013) Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121, 4036-4045
36. Boohaker, R. J., and Xu, B. (2014) The versatile functions of ATM kinase. Biomed. J. 37, 3-9
37. Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., Fulton, L., Fulton, R. S., Zhang, Q., Wendl, M. C., Lawrence, M. S., Larson, D. E., Chen, K., Dooling, D. J., Sabo, A., Hawes, A. C., Shen, H., Jhangiani, S. N., Lewis, L. R., Hall, O., Zhu, Y., Mathew, T., Ren, Y., Yao, J., Scherer, S. E., Clerc, K., Metcalf, G. A., Ng, B., Milosavljevic, A., Gonzalez-Garay, M. L., Osborne, J. R., Meyer, R., Shi, X., Tang, Y., Koboldt, D. C., Lin, L., Abbott, R., Miner, T. L., Pohl, C., Fewell, G., Haipek, C., Schmidt, H., Dunford-Shore, B. H., Kraja, A., Crosby, S. D., Sawyer, C. S., Vickery, T., Sander, S., Robinson, J., Winckler, W., Baldwin, J., Chirieac, L. R., Dutt, A., Fennell, T., Hanna, M., Johnson, B. E., Onofrio, R. C., Thomas, R. K., Tonon, G., Weir, B. A., Zhao, X., Ziaugra, L., Zody, M. C., Giordano, T., Orringer, M. B., Roth, J. A., Spitz, M. R., Wistuba, II, Ozenberger, B., Good, P. J., Chang, A. C., Beer, D. G., Watson, M. A., Ladanyi, M., Broderick, S., Yoshizawa, A., Travis, W. D., Pao, W., Province, M. A., Weinstock, G. M., Varmus, H. E., Gabriel, S. B., Lander, E. S., Gibbs, R. A., Meyerson, M., and Wilson, R. K. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075
38. von Stechow, L., van de Water, B., and Danen, E. H. (2013) Unraveling DNA damage response-signaling networks through systems approaches. Arch. Toxicol. 87, 1635-1648
39. Chatterjee, N., and Siede, W. (2013) Replicating damaged DNA in eukaryotes. Cold Spring Harb. Perspect. Biol. 5, a019836
40. Maréchal, A., and Zou, L. (2013) DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 5, a012716